5YVF
 
 | Crystal structure of BFA1 | Descriptor: | BFA1 | Authors: | Pu, H, Zhang, L, Duan, Z.K, Peng, L.W, Liu, L. | Deposit date: | 2017-11-25 | Release date: | 2018-08-08 | Last modified: | 2024-03-27 | Method: | X-RAY DIFFRACTION (2.804 Å) | Cite: | Nucleus-Encoded Protein BFA1 Promotes Efficient Assembly of the Chloroplast ATP Synthase Coupling Factor 1. Plant Cell, 30, 2018
|
|
8IG4
 
 | Crystal structure of SARS-Cov-2 main protease in complex with GC376 | Descriptor: | Non-structural protein 11, N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Authors: | Zhou, X.L, Zhang, J, Li, J. | Deposit date: | 2023-02-20 | Release date: | 2024-03-06 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376. J.Mol.Biol., 436, 2024
|
|
8IG5
 
 | Crystal structure of SARS main protease in complex with GC376 | Descriptor: | 3C-like proteinase nsp5, N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Authors: | Lin, C, Zhang, J, Li, J. | Deposit date: | 2023-02-20 | Release date: | 2024-03-06 | Last modified: | 2024-11-13 | Method: | X-RAY DIFFRACTION (2.17 Å) | Cite: | Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376. J.Mol.Biol., 436, 2024
|
|
8IG6
 
 | Crystal structure of MERS main protease in complex with GC376 | Descriptor: | N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide, ORF1a | Authors: | Lin, C, Zhang, J, Li, J. | Deposit date: | 2023-02-20 | Release date: | 2024-03-06 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (2.07 Å) | Cite: | Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376. J.Mol.Biol., 436, 2024
|
|
8IG7
 
 | |
8IG8
 
 | |
8IG9
 
 | |
8IGA
 
 | |
1TY4
 
 | Crystal structure of a CED-9/EGL-1 complex | Descriptor: | Apoptosis regulator ced-9, EGg Laying defective EGL-1, programmed cell death activator | Authors: | Yan, N, Gu, L, Kokel, D, Xue, D, Shi, Y. | Deposit date: | 2004-07-07 | Release date: | 2004-09-28 | Last modified: | 2024-11-20 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Structural, Biochemical, and Functional Analyses of CED-9 Recognition by the Proapoptotic Proteins EGL-1 and CED-4 Mol.Cell, 15, 2004
|
|
8WY7
 
 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 22 | Descriptor: | 2-[[5-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-1-methyl-2-oxidanylidene-pyridin-4-yl]amino]-~{N}-(4-oxidanylcyclohexyl)ethanamide, Bromodomain-containing protein 4 | Authors: | Xu, H, Zhao, X, Shen, H, Xu, Y, Wu, X. | Deposit date: | 2023-10-30 | Release date: | 2024-01-24 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.83 Å) | Cite: | Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J.Med.Chem., 67, 2024
|
|
9JK4
 
 | putative E2P of TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-15 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (2.82 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
9JK3
 
 | putative MgE2P of TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-14 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (2.45 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
9JJN
 
 | putative MgE1-ATP of human TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-14 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (2.49 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
8WY3
 
 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 21 | Descriptor: | Bromodomain-containing protein 4, ~{N}-cyclopropyl-2-[[5-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-1-methyl-2-oxidanylidene-pyridin-4-yl]amino]ethanamide | Authors: | Xu, H, Zhao, X, Shen, H, Xu, Y, Wu, X. | Deposit date: | 2023-10-30 | Release date: | 2024-01-24 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.78 Å) | Cite: | Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J.Med.Chem., 67, 2024
|
|
9JJO
 
 | putative MgE1P-ADP of human TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-14 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (3.24 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
8WYG
 
 | Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor 22 | Descriptor: | 2-[[5-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-1-methyl-2-oxidanylidene-pyridin-4-yl]amino]-~{N}-(4-oxidanylcyclohexyl)ethanamide, Bromodomain-containing protein 2 | Authors: | Xu, H, Zhao, X, Shen, H, Xu, Y, Wu, X. | Deposit date: | 2023-10-30 | Release date: | 2024-01-24 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (3.13 Å) | Cite: | Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J.Med.Chem., 67, 2024
|
|
8WXY
 
 | Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor 23 | Descriptor: | 5-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-1-methyl-4-[(2-morpholin-4-yl-2-oxidanylidene-ethyl)amino]pyridin-2-one, Bromodomain-containing protein 4, GLYCEROL | Authors: | Xu, H, Zhao, X, Shen, H, Xu, Y, Wu, X. | Deposit date: | 2023-10-30 | Release date: | 2024-01-24 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.87 Å) | Cite: | Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J.Med.Chem., 67, 2024
|
|
9JK5
 
 | putative MgE1-ATP-H of TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-15 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (2.92 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
9JJK
 
 | putative MgE1 of human TMEM94 | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Endoplasmic reticulum magnesium-transporting P-type ATPase | Authors: | Gong, D.S. | Deposit date: | 2024-09-14 | Release date: | 2025-06-11 | Method: | ELECTRON MICROSCOPY (2.59 Å) | Cite: | Structural analysis of full-length human transmembrane protein 94 argues against its classification as a P-type Mg 2+ ATPase. Cell Discov, 11, 2025
|
|
9H3I
 
 | trans-aconitate decarboxylase Tad1- wild type | Descriptor: | Trans-aconitate decarboxylase 1 | Authors: | Zheng, L, Bang, G. | Deposit date: | 2024-10-16 | Release date: | 2025-03-19 | Method: | X-RAY DIFFRACTION (2.31 Å) | Cite: | Mechanistic and structural insights into the itaconate-producing trans -aconitate decarboxylase Tad1. Pnas Nexus, 4, 2025
|
|
9H4G
 
 | |
9H4H
 
 | trans-aconitate decarboxylase Tad1_S320A | Descriptor: | Trans-aconitate decarboxylase 1 | Authors: | Zheng, L, Bange, G. | Deposit date: | 2024-10-18 | Release date: | 2025-03-19 | Method: | X-RAY DIFFRACTION (2.09 Å) | Cite: | Mechanistic and structural insights into the itaconate-producing trans -aconitate decarboxylase Tad1. Pnas Nexus, 4, 2025
|
|
9H4E
 
 | |
5XA6
 
 | |
6M31
 
 | |